American Medical Software Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • American Medical Software's estimated annual revenue is currently $507.5k per year.(i)
  • American Medical Software's estimated revenue per employee is $72,500

Employee Data

  • American Medical Software has 7 Employees.(i)

American Medical Software's People

NameTitleEmail/Phone
1
OwnerReveal Email/Phone
2
Technical DirectorReveal Email/Phone
3
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$907.8M4472N/AN/AN/A
#2
$1500M5889-10%$100M$2.2B
#3
$16.4M117-6%$157.5MN/A
#4
$15.9M122-1%N/AN/A
#5
$1651.9M82515%$40MN/A
#6
$45.3M28425%N/AN/A
#7
$143.1M7053%N/AN/A
#8
$24.4M162-8%$60.7MN/A
#9
$333.7M16678%$332.6M$1B
#10
$23.3M146N/AN/AN/A
#11
$1.4M16N/AN/AN/A
#12
$5.8M50N/AN/AN/A
#13
$395M1045N/AN/AN/A
#14
$206.9M613N/AN/AN/A
#15
$83.4M4539%$10.7MN/A
#16
$207.2M61427%N/AN/A
#17
$3.6M31-9%N/AN/A
#18
$64.9M358N/AN/AN/A
#19
$62.4M210N/AN/AN/A
#20
$1.6M18N/AN/AN/A
Add Company

What Is American Medical Software?

keywords:N/A

N/A

Total Funding

7

Number of Employees

$507.5k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

American Medical Software News

2022-04-20 - Medical Billing Software Market forces, Consumption ...

Insta Health Solutions; bflow Solutions; American Medical Software; Meditab Software; Kareo; TotalMD; Navicure; Insta Medical Care. Get a sample...

2022-04-20 - Medical Scheduling Systems Market Growth 2022-2030| Key ...

Medical Scheduling Systems Market Growth 2022-2030| Key Players – TimeTrade Systems, Yocale, American Medical Software, Voicent Communications.

2022-04-17 - Global Medical Scheduling Tools Market 2022 Industry ...

Global Medical Scheduling Tools Market 2022 Industry Challenges by Players – TimeTrade Systems, Yocale, American Medical Software, Voicent...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M740%N/A
#2
$0.6M80%N/A
#3
$0.9M100%N/A
#4
$1.3M120%N/A
#5
$2.1M13-7%N/A